OMIC Singular Genomics Systems Inc Yalpi foyda marjasi

Singular Genomics Systems Inc (OMIC) kompaniyasining rasmiy ramzlari

Singular Genomics Systems kompaniyasining biofarmatsevtika sektori xomashyo logistikasining zaifligiga qaramay, barqaror talabga tayanadi. Kompaniya daromadlari sekvenslash tizimlari va sarf materiallarining sotuviga asoslangan. Valo’y foyda marjalari ushbu modelning barqarorligini aniq tasdiqlaydi, bunda -307.60 qiymati ushbu darajani xarakterlaydi. Biroq, narxlarni belgilashdagi past imkoniyatlar Singular Genomics Systems (OMIC) kompaniyasini bozor yetakchilari bilan raqobatlashish uchun uskunalar xarajatlarini kamaytirishga majbur qilmoqda.

Singular Genomics (OMIC): Yalpi marja 04.07.2022dan 01.03.2025gacha

singulargenomics.com (OMIC) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

Kompaniyaning jamlanma tahlili:Singular Genomics Systems, Inc. (OMIC)
Singular Genomics Systems asosiy tovari

Yalpi marja mahsulotni yaratishning bevosita xarajatlarini qoplashdan keyin qolgan daromad qismini aniqlash orqali ishlab chiqarish samaradorligini o'lchaydi. Yalpi foyda marjalarini tahlil qilish orqali investor biznesning qo'shimcha qiymat yaratish va moliyaviy barqarorlikni ta'minlash qobiliyatini baholaydi. Singular Genomics (OMIC) uchun ushbu ko'rsatkich yuqori malakali muhandislik jamoasiga va DNK sekvensirlash sohasidagi innovatsion ishlanmalarga kiritilgan investitsiyalarning rentabelligini aks ettiradi.

Asosiy raqobatchilar

Yalpi foyda bo'yicha rentabellik Tempus AI Inc|QGEN (Qiagen NV) - Yalpi marja|Yalpi foyda bo'yicha rentabellik Ionis Pharma (IONS)|Yalpi rentabellik Repligen Corp (RGEN)|RNA - Yalpi foyda marjasi|crisprtx.com - Yalpi foyda bo'yicha rentabellik|Yalpi foyda normasi WGS|RARE - Yalpi rentabellik|Beam Tx (BEAM) - Yalpi foyda bo'yicha rentabellik|SRPT (Sarepta Therapeutics Inc) - Yalpi foyda bo'yicha rentabellik|TWST: Yalpi foyda koeffitsiyenti|TXG (10xgenomics.com) - Yalpi marja|NTLA (Intellia Therapeutics, Inc.) - Yalpi foyda koeffitsiyenti|Yalpi rentabellik Stoke Corp (STOK)|Yalpi foyda bo'yicha sotuv rentabelligi BioLife|Yalpi marja WVE (Wave Life Sciences Ltd)|MAZE: Sotuvning yalpi rentabelligi|Sionna Therapeutics, Inc. - Yalpi marja|Yalpi foyda normasi PRME (Prime Medicine Inc)|TSHA (Taysha Gene Therapies, Inc.) - Yalpi foyda bo'yicha rentabellik|QURE - Yalpi foyda bo'yicha sotuv rentabelligi|MGTX (MeiraGTx Corp) - Yalpi marja|Yalpi foyda marjasi REGENXBIO Inc. RGNX|Yalpi rentabellik Solid Biosciences (SLDB)|Ocugen Corp - Sotuvning yalpi rentabelligi|Yalpi rentabellik Pacific Biosciences PACB|Yalpi foyda koeffitsiyenti BNTC (Benitec)|Design Corp - Yalpi marja|Rocket Pharmaceuticals - Yalpi foyda koeffitsiyenti|Sotuvning yalpi rentabelligi 4D Molecular Therapeutics, Inc.|Yalpi foyda marjasi Lexeo Therapeutics (LXEO)|KRRO (Korro Bio, Inc.) - Yalpi marja|Yalpi foyda marjasi Editas EDIT|Yalpi marja SLN|ProQR Therapeutics - Sotuvning yalpi rentabelligi|Yalpi marja CDXS (Codexis, Inc.)|SGMO: Sotuvning yalpi rentabelligi|Nautilus Biotechnology - Yalpi marja|Yalpi foyda normasi MGX (Metagenomi, Inc)|DTIL: Yalpi marja|GBIO: Yalpi foyda koeffitsiyenti|Yalpi rentabellik Boundless Bio Inc.|Yalpi foyda bo'yicha rentabellik Exicure (XCUR)|Yalpi marja IMNN|PHIO (Phio Pharmaceuticals Corp.) - Yalpi foyda normasi|Mustang Bio, Inc. - Yalpi foyda bo'yicha rentabellik|RNAZ - Yalpi foyda bo'yicha rentabellik|BNGO: Yalpi foyda bo'yicha rentabellik|APDN (Applied DNA Sciences Inc) - Sotuvning yalpi rentabelligi|BLUE (Bluebird Bio) - Yalpi foyda bo'yicha rentabellik|ImmunoPrecise Antibodies Ltd - Yalpi foyda normasi|OMGA (Omega Therapeutics Inc) - Yalpi marja|Yalpi foyda marjasi regulusrx.com RGLS|Yalpi rentabellik Syros Pharmaceuticals Inc. (SYRS)|Yalpi foyda bo'yicha sotuv rentabelligi Codex DNA|Yalpi rentabellik TRACON TCON|Unity Biotechnology, Inc - Yalpi rentabellik